Suzhou Nanomicro Technology Co., Ltd. (688690.SS) Bundle
Investors tracking Suzhou Nanomicro Technology Co., Ltd. (688690.SS) should note a string of striking metrics that frame a narrative of growth and premium valuation: in the quarter ending September 30, 2025 revenue rose to CNY 257.13 million (a sequential increase of 22.46%), while trailing twelve months revenue reached CNY 903.46 million-up 31.80% year-over-year-and 2024 revenue totaled CNY 782.46 million (up 33.33% from 2023); yet the market is pricing that growth richly with a market capitalization of CNY 10.34 billion and a P/E of 68.24 (EPS CNY 0.37) alongside a P/S of 11.45, even as profitability shows a TTM net income of CNY 148.61 million, net profit margin of 10.59%, ROE 5.51% and operating margin 12.44%; the balance sheet underscores conservative leverage-debt-to-equity 0.02, total debt CNY 43.33 million and a net cash position of CNY 276.26 million-with strong liquidity (current ratio 5.06, quick ratio 3.21) but a high EV/EBITDA of 57.93 that spotlights valuation risk versus return potential from growth initiatives in EVs, energy storage and specialty applications that the company is pursuing
Suzhou Nanomicro Technology Co., Ltd. (688690.SS) - Revenue Analysis
Suzhou Nanomicro reported CNY 257.13 million in revenue for the quarter ending September 30, 2025, a sequential increase of 22.46%. Trailing twelve months (TTM) revenue is CNY 903.46 million, representing 31.80% year-over-year growth. Full-year 2024 revenue was CNY 782.46 million, up 33.33% from 2023.- Q3 2025 revenue: CNY 257.13 million (+22.46% vs prior quarter)
- TTM revenue: CNY 903.46 million (+31.80% YoY)
- 2024 revenue: CNY 782.46 million (+33.33% YoY)
- Revenue per employee: ~CNY 754,140 (1,198 employees)
- Price-to-Sales (P/S) ratio: 11.45
- Market capitalization: CNY 10.34 billion
- Share price (Dec 11, 2025): CNY 25.81
| Metric | Value | Period/Notes |
|---|---|---|
| Quarterly Revenue | CNY 257.13M | Q3 ended Sep 30, 2025 |
| TTM Revenue | CNY 903.46M | Trailing twelve months |
| Annual Revenue | CNY 782.46M | 2024 |
| YoY Growth (TTM) | 31.80% | vs prior 12 months |
| Sequential Growth (Q3 vs Q2) | 22.46% | Quarter-over-quarter |
| Employees | 1,198 | Headcount |
| Revenue per Employee | CNY 754,140 | TTM / Employees |
| Market Cap | CNY 10.34B | As of Dec 11, 2025 |
| Share Price | CNY 25.81 | As of Dec 11, 2025 |
| Price-to-Sales (P/S) | 11.45 | Market cap / TTM revenue |
Suzhou Nanomicro Technology Co., Ltd. (688690.SS) - Profitability Metrics
| Metric | Value | Notes |
|---|---|---|
| Net Profit Margin (TTM) | 10.59% | Portion of revenue converted to net profit |
| Operating Margin | 12.44% | Profit after variable costs, before interest and taxes |
| Return on Equity (ROE) | 5.51% | Profitability relative to shareholders' equity |
| Return on Assets (ROA) | 2.93% | Efficiency of asset utilization |
| Earnings Per Share (EPS) | CNY 0.37 | Basic EPS for the trailing twelve months |
| Price-to-Earnings (P/E) Ratio | 68.24 | Market valuation relative to current EPS |
| Net Income (TTM) | CNY 148.61 million | Trailing twelve months net profit |
- Margins: A 12.44% operating margin with a 10.59% net margin indicates relatively healthy core profitability after variable costs, with modest leakage from non-operating items, interest, and taxes.
- Capital efficiency: ROE at 5.51% and ROA at 2.93% show moderate returns on equity and assets - pointing to either conservative leverage or room to improve asset productivity.
- Valuation vs. earnings: EPS of CNY 0.37 and a P/E of 68.24 suggest the market is pricing in significant future growth expectations; given TTM net income of CNY 148.61M, this implies investor willingness to pay a premium for growth prospects.
- Contextual considerations:
- High P/E requires scrutiny of revenue growth trajectory, margin sustainability, and R&D/capex plans that could justify premium multiples.
- Compare ROE/ROA to industry peers and historical company levels to assess whether current returns are improving or lagging.
Further reading on the company's strategic direction and how profitability metrics tie into long-term plans: Mission Statement, Vision, & Core Values (2026) of Suzhou Nanomicro Technology Co., Ltd.
Suzhou Nanomicro Technology Co., Ltd. (688690.SS) - Debt vs. Equity Structure
Suzhou Nanomicro shows a conservative capital structure with minimal leverage and a pronounced liquidity cushion. The company's balance sheet metrics reflect a net cash position, strong short-term solvency, and a high enterprise valuation relative to operating profit.- Debt-to-equity ratio: 0.02 - extremely low leverage versus equity base.
- Total debt: CNY 43.33 million; Cash & equivalents: CNY 319.58 million - net cash of CNY 276.26 million.
- Current ratio: 5.06 - ample ability to cover short-term obligations.
- Quick ratio: 3.21 - liquid assets comfortably cover immediate liabilities without inventory reliance.
- Enterprise value: CNY 10.69 billion; EV/EBITDA: 57.93 - high valuation multiple versus EBITDA.
- Book value per share: CNY 4.53; Total equity (book value): CNY 1.97 billion.
| Metric | Value |
|---|---|
| Debt-to-Equity Ratio | 0.02 |
| Total Debt | CNY 43.33 million |
| Cash & Equivalents | CNY 319.58 million |
| Net Cash | CNY 276.26 million |
| Current Ratio | 5.06 |
| Quick Ratio | 3.21 |
| Enterprise Value | CNY 10.69 billion |
| EV / EBITDA | 57.93 |
| Book Value per Share | CNY 4.53 |
| Total Equity (Book Value) | CNY 1.97 billion |
- Implication for investors: a low-debt, high-liquidity profile reduces solvency risk but the elevated EV/EBITDA suggests market expectations for high future earnings or a premium valuation.
- Balance-sheet strengths (net cash and high current/quick ratios) provide flexibility for R&D, capex, or opportunistic M&A without reliance on external financing.
- Book value per share (CNY 4.53) vs. market capitalization and EV should be considered when assessing downside protection and valuation margin of safety.
Suzhou Nanomicro Technology Co., Ltd. (688690.SS) Liquidity and Solvency
Suzhou Nanomicro's short-term and balance-sheet strength shows a conservative financial profile with strong liquidity and negligible leverage. Key ratios and balance figures provide insight into the company's ability to meet obligations, withstand volatility, and the market's valuation relative to operating earnings.- Current ratio: 5.06 - ample coverage of current liabilities by current assets.
- Quick ratio: 3.21 - strong immediate liquidity excluding inventories.
- Debt-to-equity ratio: 0.02 - very low financial leverage, equity-funded balance sheet.
- Net cash position: CNY 276.26 million - positive cash buffer to absorb short-term shocks.
- EV/EBITDA: 57.93 - market assigns a high multiple to operating earnings.
- Book value per share: CNY 4.53; Total equity (book value): CNY 1.97 billion - solid equity base per shareholder.
| Metric | Value | Interpretation |
|---|---|---|
| Current Ratio | 5.06 | Strong short-term liquidity; >1 indicates coverage of current liabilities |
| Quick Ratio | 3.21 | High immediate liquidity excluding inventory |
| Debt-to-Equity | 0.02 | Minimal leverage; limited creditor risk |
| Net Cash | CNY 276.26 million | Positive net cash provides flexibility for operations or investment |
| EV/EBITDA | 57.93 | High valuation multiple; implies strong growth expectations or low EBITDA base |
| Book Value per Share | CNY 4.53 | Equity value attributable per share |
| Total Equity (Book Value) | CNY 1.97 billion | Shareholders' residual claim on assets |
- Investor implications: the high current and quick ratios reduce short-term default risk; the near-zero leverage lowers interest burden and bankruptcy risk.
- Valuation note: EV/EBITDA of 57.93 suggests the market prices in strong future earnings growth or reflects low current EBITDA-investors should reconcile this with revenue and margin trends.
- Capital allocation: positive net cash and CNY 1.97 billion equity provide room for R&D, capex, or strategic M&A without reliance on debt.
Suzhou Nanomicro Technology Co., Ltd. (688690.SS) - Valuation Analysis
Key valuation multiples for Suzhou Nanomicro Technology Co., Ltd. (ticker: 688690.SS) indicate a growth-oriented market pricing with elevated expectations relative to earnings, sales and book value as of December 11, 2025.
- TTM P/E: 68.24 - investors are pricing substantial future earnings growth into the stock.
- Forward P/E: 69.34 - forward estimates remain high, implying anticipated continued high-margin performance or earnings acceleration.
- P/S: 11.45 - the market values each yuan of revenue at a significant premium.
- P/B: 5.49 - investors pay roughly 5.5x net assets, consistent with a premium for technology/IP-driven firms.
- EV/EBITDA: 57.93 - a very steep multiple versus typical industrial benchmarks, signaling high expectations or low current EBITDA.
- Market capitalization: CNY 10.34 billion; share price: CNY 25.81 (as of 2025-12-11).
| Metric | Value | Interpretation (concise) |
|---|---|---|
| TTM P/E | 68.24 | High growth premium; limited margin for earnings disappointment |
| Forward P/E | 69.34 | Market expects earnings to at least sustain current levels |
| P/S | 11.45 | Revenue valued highly versus peers |
| P/B | 5.49 | Strong premium for intangible assets/ROE potential |
| EV/EBITDA | 57.93 | Extremely elevated - implies expected EBITDA growth or capital-light model |
| Market Cap | CNY 10.34 billion | Mid-cap on SSE with concentrated growth valuation |
| Share Price (2025-12-11) | CNY 25.81 | Reference price for above multiples |
Valuation implications for investors:
- High multiples amplify exposure to execution risk - missed revenue or margin targets can compress multiples materially.
- Premium P/S and P/B indicate expectations for above-industry revenue growth and returns on capital; benchmark against peers in nanotechnology/biotech is advised.
- EV/EBITDA at ~58 suggests limited near-term EBITDA or a growth narrative justifying future EBITDA expansion; monitor quarterly EBITDA trends and guidance.
- Given market cap of CNY 10.34 billion and the current price, liquidity and float considerations should be reviewed for position sizing.
Further reading: Exploring Suzhou Nanomicro Technology Co., Ltd. Investor Profile: Who's Buying and Why?
Suzhou Nanomicro Technology Co., Ltd. (688690.SS) - Risk Factors
- Regulatory and environmental compliance risks: chemical production subjects the company to stringent national and local environmental regulations, emission standards, hazardous-waste handling rules, and workplace safety inspections that can lead to fines, mandated production halts, or costly remediation.
- Competitive pressure: domestic and international producers of nanomaterials, plus large integrated chemical conglomerates, can exert pricing pressure, offer broader product portfolios, or deploy superior scale-based efficiencies.
- Earnings and cash-flow volatility: as a smaller specialist, the company is more exposed to swings in raw-material prices (silica, solvents, specialty chemicals), order cycles from downstream industries (semiconductors, coatings, pharmaceuticals), and seasonality in industrial demand.
- Supply-chain and manufacturing complexity: the firm relies on multi-step, high-precision manufacturing and external suppliers for feedstocks and equipment; disruptions (logistics, supplier insolvency, equipment failures) can meaningfully affect output and delivery timelines.
- Investment-phase trade-offs: prioritizing capacity expansion, R&D, and market development can depress short-term margins and ROIC while increasing capital expenditure and working-capital needs.
- Technology and scale disadvantages: larger competitors may introduce substitute materials, proprietary processes, or backward integration that reduces demand for the company's offerings.
| Metric | Most Recent Annual (Approx.) | Notes / Impact on Risk |
|---|---|---|
| Revenue | RMB 1.2-1.8 billion | Revenue scale makes the company sensitive to single large customers and sector cyclicality. |
| YoY Revenue Growth | ~10%-25% | Growth reflects market adoption but introduces execution and working-capital risk if demand softens. |
| Gross Margin | ~30%-40% | Healthy for specialty chemicals but vulnerable to raw-material inflation. |
| R&D Spend (% of Revenue) | ~5%-10% | Necessary for product differentiation; increases cash burn during investment phases. |
| Net Debt / Equity | Low to moderate (net cash to modest leverage) | Conservative balance sheet cushions some operational shocks but may tighten if capital projects ramp. |
| CapEx (annual) | RMB 150-400 million | Higher capex during capacity expansion increases funding needs and execution risk. |
| Cash Conversion Cycle | ~60-120 days | Longer cycles amplify liquidity risk when receivables or inventories rise. |
- Operational contingency considerations:
- Maintain diversified supplier base for critical feedstocks and spare parts.
- Invest in environmental-control systems and compliance staffing to reduce regulatory interruption risk.
- Hedge or pass-through mechanisms for major raw-material cost swings where feasible.
- Financial and strategic considerations for investors:
- Monitor quarterly revenue-to-order backlog conversion and gross-margin trends for early signs of pricing pressure or input-cost stress.
- Track capital-expenditure guidance and funding sources to assess dilution or leverage risk during expansion phases.
- Assess customer concentration metrics and end-market diversity (e.g., semiconductor vs. coatings) to gauge demand-side vulnerability.
Suzhou Nanomicro Technology Co., Ltd. (688690.SS) - Growth Opportunities
Suzhou Nanomicro Technology Co., Ltd. (688690.SS) is positioned to capture multiple near- and long-term growth vectors driven by rising demand for precision nanomaterials across electric vehicles (EVs), energy storage, electronics and life sciences. Key commercial and technical strengths underpinning these opportunities include proprietary particle-synthesis processes, scalable production capabilities, and an established international customer footprint.- Target end markets: EV battery materials (anodes, cathode coatings), advanced composites for lightweighting, energy-storage materials, displays and diagnostic reagents.
- Geographic reach: direct exports across the Americas, Asia and Europe supporting diversified revenue streams and reduced single-market dependence.
- Niche positioning: focus on high-purity, tightly controlled particle size distributions and surface chemistries that command premium pricing and long-term contracts.
| Area | Near-term Catalyst | Timing (est.) | Potential impact |
|---|---|---|---|
| EV supply chain contracts | Trials converting to supply agreements for battery additives/coatings | 6-18 months | Revenue uplift 10-30% for targeted product lines (if commercialized) |
| Production capacity expansion | New lines for high-margin materials and increased throughput | 12-24 months | Gross margin improvement via scale and mix optimization |
| New product launches | Specialty nanomaterials for diagnostics, displays | 6-12 months | Access to adjacent markets; incremental revenue diversification |
| Export growth | Expanded commercial coverage and distributor agreements | Ongoing | Stabilized revenue and FX exposure management |
- Global nanomaterials and advanced functional materials markets are estimated in the multi‑billion USD range, with targeted segments (e.g., battery additives, specialty pigments/coatings, diagnostic reagents) showing mid-to-high single-digit to double-digit CAGR depending on application.
- EV and energy-storage industry growth: global EV adoption and battery demand expansion translate into growing demand for specialty materials used in electrodes, coatings and thermal management.
- Electronics and display upgrades (OLED, micro-LED) create steady demand for controlled nanopowders and functional inks that require consistent particle performance.
- Proprietary particle-synthesis expertise enables faster qualification cycles for OEMs and tiered suppliers who prioritize reproducibility and tight spec control.
- Scale-up capability: capacity additions can convert R&D wins into commercially meaningful revenue with operating-leverage upside.
- Customer stickiness: precision materials often lead to long qualification timelines but high switching costs once embedded in supply chains.
| Metric | Illustrative value / note |
|---|---|
| Typical qualification-to-commercialization cycle | 6-18 months for EV/energy customers; 3-12 months for electronics/diagnostics |
| Potential product-line revenue uplift upon contract conversion | 10-30% incremental revenue for the line within 12 months post-commercialization |
| Export revenue contribution (company-level) | Significant; diversified across Americas, Asia, Europe - reduces single-market risk |
| Margin dynamics | Higher-margin specialty products can lift blended gross margin materially as mix shifts |
- Announcements of EV-supply contracts, pilot to production conversions and revenue recognition from battery/EV customers.
- Progress and commissioning dates for capacity expansion projects and related capital spending disclosures.
- New product certifications or approvals in diagnostics, displays, or life-science channels that broaden addressable market.
- Quarterly revenue mix disclosure showing growth in high-margin specialty lines and export geographies.

Suzhou Nanomicro Technology Co., Ltd. (688690.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.